Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop ... Evaxion has developed a clinical-stage oncology ...

As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with Nas ...

We're committed to driving innovation to further differentiate our technologies and to bolster our pipeline and we're excited ...

Fractyl Health, Inc. ( (GUTS) ) has released its Q3 earnings. Here is a breakdown of the information Fractyl Health, Inc. presented to its ...

Who doesn’t love software that works seamlessly right out of the box? In today’s fast-paced digital world, users expect ...

Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 ...

November 12, 2024NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.27. Operator: ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

We'll face pressure on trade, taxes, defence, energy and climate change and our relations with other countries. Best to start ...

The UK and Canada, leveraging their strengths as trusted middle powers, are well-positioned to lead in setting global AI ...

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, ...

BWX Technologies Inc, NexGen Energy Ltd., NexGen Energy Ltd., Vistra Energy Corp. Read The Tokenist (Timothy Fries)'s latest article on Investing.com ...